BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2018

Oct 6, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2018-10-03

Reporting Person: Ajer Jeffrey Robert (EVP, Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-10-03	Common Stock	S	1000	$98.9848	Disposed	49135	Direct

Footnotes

F1: Trade made pursuant to a 10b5-1 plan executed on September 10, 2018.

F2: The price in column 4 is the weighted average price. The price actually received ranged from $98.76 to $99.18. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.